Literature DB >> 3007289

New vectors for construction of recombinant high-copy-number yeast acentric-ring plasmids.

M C Fagan, J F Scott.   

Abstract

Yeast acentric-ring plasmid 1 (YARp1), comprising 1453 bp of entirely yeast chromosomal DNA, is maintained in Saccharomyces cerevisiae as a high-copy, relatively stable plasmid. To determine the feasibility of using YARp1 as a yeast cloning vehicle, we subcloned the GAL1-10 promoter and the URA3 gene into YARp1 at different locations. To facilitate these constructions, a class of permuted YARp1 construction vectors was generated which enabled us to use various restriction sites in YARp1 as insertion points. Transformation frequencies, plasmid stabilities, and copy numbers of these YARp1 derivatives remained elevated, comparable to those of YARp1 itself. Also, when OMP decarboxylase was assayed using strains containing URA3-YARp's, specific activities of 100-300 times that of wild type were found. This evidence supports the use of YARp1 as a high-copy yeast-expression vector or for analyzing structural and regulatory DNA sequences.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3007289     DOI: 10.1016/0378-1119(85)90044-7

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  Use of yeast nuclear DNA sequences to define the mitochondrial RNA polymerase promoter in vitro.

Authors:  G T Marczynski; P W Schultz; J A Jaehning
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

2.  A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic.

Authors:  T Imbach; P Burda; P Kuhnert; R A Wevers; M Aebi; E G Berger; T Hennet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  A rapid procedure for the transformation of Saccharomyces cerevisiae by plasmids extracted from yeasts.

Authors:  D Keszenman-Pereyra; K Hieda
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.